Feature Papers of Radiation 2022

A special issue of Radiation (ISSN 2673-592X).

Deadline for manuscript submissions: closed (31 December 2022) | Viewed by 7624

Special Issue Editor


E-Mail Website
Guest Editor
Central Institute for Translational Cancer Research (TranslaTUM), Klinikum rechts der Isar der Technischen Universität München, 81675 Munich, Germany
Interests: radiation oncology; NK cell based immunotherapies; preclinical models; tumor biomarker; molecular tumor imaging
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

We are pleased to announce a Special Issue entitled "Feature Papers of Radiation 2022", which will be one of the first of a new journal, /Radiation/. /Radiation/ is an international, peer-reviewed, open access journal on scientific advances and applications of radiotherapy, immunotherapy, radiology, and radiation technologies across multiple fields. The journal will complete the group of international journals in the field of radiology, and we are expecting to gain popularity and prestige very soon.

In this Special Issue, we are willing to receive manuscripts from all radiology fields considered to be of interest to our international readers. In this case, well-designed studies and good datasets are required to promote the quality of, and interest in, our new journal. We welcome both original research articles and comprehensive review papers. The papers in this Special Issue will be published via our open access platform after a thorough peer review, a process which will benefit both our authors and readers.

As evidenced by the keywords list, the fields to be included in this Special Issue have been broadened to best represent the scope of the journal, whilst opening up more chances for international research contributions.

You are welcome to send short proposals for feature paper submissions to the Editorial Office (radiation@mdpi.com) before submission.

We look forward to receiving your excellent work

Prof. Dr. Gabriele Multhoff
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Radiation is an international peer-reviewed open access quarterly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • radiotherapy
  • radio-immunotherapy
  • radiation biology
  • radiation physics
  • irradiation
  • radiation dosimetry
  • radiation sources
  • radiation sensitivity
  • imaging

Published Papers (2 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Review

Jump to: Other

18 pages, 1879 KiB  
Review
Physical Differences between Man-Made and Cosmic Microwave Electromagnetic Radiation and Their Exposure Limits, and Radiofrequencies as Generators of Biotoxic Free Radicals
by Christos D. Georgiou, Electra Kalaitzopoulou, Marianna Skipitari, Polyxeni Papadea, Athina Varemmenou, Vassilios Gavriil, Evangelia Sarantopoulou, Zoe Kollia and Alkiviadis-Constantinos Cefalas
Radiation 2022, 2(4), 285-302; https://doi.org/10.3390/radiation2040022 - 22 Sep 2022
Cited by 4 | Viewed by 4873
Abstract
The critical arguments for radiofrequency radiation exposure limits are currently based on the principle that radio frequencies (RF) and electromagnetic fields (EMFs) are non-ionising, and their exposure limits are even 100-fold lower than those emitted from the Sun in the whole RF-EMF spectrum. [...] Read more.
The critical arguments for radiofrequency radiation exposure limits are currently based on the principle that radio frequencies (RF) and electromagnetic fields (EMFs) are non-ionising, and their exposure limits are even 100-fold lower than those emitted from the Sun in the whole RF-EMF spectrum. Nonetheless, this argument has been challenged by numerous experimental and theoretical studies on the diverse biological effects of RF-EMF at much lower power density (W/m2) levels than today’s exposing limits. On the other hand, less attention has been given to counterarguments based on the differences in the physics concepts underlying man-made versus natural electromagnetic radiation (EMR) and on the fact that man’s biology has been adapted to the natural EMR levels reaching Earth’s surface at single EMF wavelengths, which are the natural limits of man’s exposure to EMFs. The article highlights the main points of interaction of natural and man-made radiation with biomatter and reveals the physical theoretical background that explains the effects of man-made microwave radiation on biological matter. Moreover, the article extends its analysis on experimental quantum effects, establishing the “ionising-like” effects of man-made microwave radiation on biological matter. Full article
(This article belongs to the Special Issue Feature Papers of Radiation 2022)
Show Figures

Figure 1

Other

Jump to: Review

5 pages, 946 KiB  
Commentary
COVID-19 Update: The Golden Time Window for Pharmacological Treatments and Low Dose Radiation Therapy
by Seyed Mohammad Javad Mortazavi, B. F. Bahaaddini Baigy Zarandi, Abdollah Jafarzadeh, S. Alireza Mortazavi and Lembit Sihver
Radiation 2022, 2(3), 268-272; https://doi.org/10.3390/radiation2030020 - 20 Jul 2022
Viewed by 2181
Abstract
At the beginning of the COVID-19 emergence, many scientists believed that, thanks to the proofreading enzyme of SARS-CoV-2, the virus would not have many mutations. Our team introduced the concept of radiation at extremely low doses in an attempt to establish selected pressure-free [...] Read more.
At the beginning of the COVID-19 emergence, many scientists believed that, thanks to the proofreading enzyme of SARS-CoV-2, the virus would not have many mutations. Our team introduced the concept of radiation at extremely low doses in an attempt to establish selected pressure-free treatment approaches for COVID-19. The capacity of low-dose radiation to modulate excessive inflammatory responses, optimize the immune system, prevent the occurrence of dangerous cytokine storm, regulate lymphocyte counts, and control bacterial co-infections as well as different modalities were proposed as a treatment program for patients with severe COVID-19-associated pneumonia. There is now substantial evidence which indicates that it would be unwise not to further investigate low-dose radiation therapy (LDRT) as an effective remedy against COVID-19-associated pneumonia. Full article
(This article belongs to the Special Issue Feature Papers of Radiation 2022)
Show Figures

Figure 1

Back to TopTop